Stephanie Ann Leonard MD

Allergy & Immunology•San Diego, CA

Associate Professor, Pediatrics, UC San Diego Sch. of Medicine

Join to View Full Profile

8110 Birmingham WayBldg 28San Diego, CA 92123
Phone+1 858-966-5961
Fax+1 858-309-6301

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2005

Certifications & Licensure

CA State Medical License 2011 - 2025
NY State Medical License 2007 - 2012
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Clinical Trials

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy Start of enrollment: 2012 Aug 01
Completed
Phase 2
Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children Start of enrollment: 2013 Sep 01
Completed
Phase 2
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT Start of enrollment: 2014 Feb 06
Completed
Phase 2
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study Start of enrollment: 2014 Aug 27
Completed
Phase 2
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
COMPLETED
PHASE1, PHASE2
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) Start of enrollment: 2015 Dec 22
Completed
Phase 3
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy Start of enrollment: 2015 Dec 01
Completed
Phase 3
PALISADE Follow-on Study (ARC004) Start of enrollment: 2016 Dec 29
Completed
Phase 3
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children Start of enrollment: 2017 Jan 23
Active, not recruiting
Phase 3
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age Start of enrollment: 2017 Jul 31
COMPLETED
PHASE3
Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) Start of enrollment: 2017 Nov 02
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D Arkwright
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-14
Assessing protocol variability for food protein-induced enterocolitis syndrome oral food challenges.
Sara Anvari, Ankona Banerjee, Stephanie Leonard, Purificacion Gonzalez-Delgado, Duc T Nguyen
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-01
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.
Anna Nowak-Wegrzyn, Scott H Sicherer, Cem Akin, Sara Anvari, Lisa M Bartnikas
The Journal of Allergy and Clinical Immunology. 2025-02-01

Press Mentions

Birthing Mothers with Mother Partners Experience Disparities in Birth-Related OutcomesApril 13th, 2022
The Family of Two Mothers Faces a Large Disparity in the Outcome of Their PregnancyApril 7th, 2022
First Edition: March 29, 2022March 29th, 2022
Join now to see all

Stephanie Ann Leonard MD

Dr. Leonard is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.